The notices it replaced
1 notice since 2023, oldest first, each with its awards since FY2014.
- Posted 2023RFA-DK-23-0216 awards
- Posted 2026RFA-DK-27-108This notice, open
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 6
- 6 new
- Median first-year cost
- $1,009,029
- $5,797,072 in all
- Institutions
- 6
- 6 contact PIs
Awards by fiscal year
0
0
0
0
0
0
0
0
0
0
6
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL1
- JOSLIN DIABETES CENTER1
- UNIVERSITY OF CALIFORNIA, SAN DIEGO1
- UNIVERSITY OF VIRGINIA1
- UNIVERSITY OF WASHINGTON1
and 1 other institution
Most frequent study sections
- Special Emphasis Panel (ZDK1 GRB-T (O1))6
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2024 | Immunometabolism and the Cardio-Renal Axis in T1D-associated Atherosclerosis: Insights from the CaRe T1D Biobank1U01DK142249-01 · under RFA-DK-23-021 | Bjornstad, PetterBornfeldt, Karin E.Vaisar, Tomas | UNIVERSITY OF WASHINGTON, WA | First-year cost $1,080,680 | Study section ZDK1 |
| FY2024 | Discovery and therapeutic targeting non-coding RNAs in T1D- or T2D-associated atherosclerosis1U01DK142281-01 · under RFA-DK-23-021 | Feinberg, Mark W | BRIGHAM AND WOMEN'S HOSPITAL, MA | First-year cost $1,022,611 | Study section ZDK1 |
| FY2024 | Characterization of risk factors for excessive cardiovascular diseases (CVD) from circulating and cardiovascular tissues of people with well-controlled chronic type 1 diabetes1U01DK142331-01 · under RFA-DK-23-021 | King, George L | JOSLIN DIABETES CENTER, MA | First-year cost $1,009,308 | Study section ZDK1 |
| FY2024 | Single-cell, multi-omic investigation of epicardial adipose and coronary endothelial dysfunction in type 1 diabetes1U01DK142338-01 · under RFA-DK-23-021 | Gupta, Rajat MMajithia, Amit | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | First-year cost $1,008,750 | Study section ZDK1 |
| FY2024 | Molecular Drivers of Atherosclerosis in Diabetes1U01DK142283-01 · under RFA-DK-23-021 | Civelek, MeteMiller, Clint LOnengut, Suna | UNIVERSITY OF VIRGINIA, VA | First-year cost $962,975 | Study section ZDK1 |
| FY2024 | Substance P Metabolites and Receptors in the Pathogenesis of Cardiac Disease in Type 1 Diabetes1U01DK142329-01 · under RFA-DK-23-021 | Campbell, William BrysonLevick, Scott P | WEST VIRGINIA UNIVERSITY, WV | First-year cost $712,748 | Study section ZDK1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.